Prevalence of Helicobacter pylori infection in the Vallès Occidental, Catalonia

Marta Navarro(Corporació Sanitària Parc Taulí), Ferrán Segura(Corporació Sanitària Parc Taulí), Bernat Font(Delft University of Technology), Isabel Sanfeliú(Corporació Sanitària Parc Taulí), Xavier Calvet(Universitat Autònoma de Barcelona)
Clinical Microbiology and Infection
November 1, 1999
10.1111/j.1469-0691.1999.tb00518.x
Cited by 10

Related Papers

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
|The Lancet|2022|295
Predictive Factors for Invasive Disease Due to Penicillin-Resistant Streptococcus pneumoniae: A Population-Based Study
|Clinical Infectious Diseases|1994|219
Clinical and Laboratory Characteristics of 144 Patients with Mediterranean Spotted Fever
|European Journal of Clinical Microbiology & Infectious Diseases|2003|212
Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever
|Antimicrobial Agents and Chemotherapy|1990|56
Deep Reinforcement Learning for Flow Control Exploits Different Physics for Increasing Reynolds Number Regimes
|Actuators|2022|52